Chapusot C, Martin L, Mungra N, Rageot D, Bouvier A M, Bonithon Kopp C, Ponnelle T, Faivre J, Piard F
Service d'Anatomie Pathologique, CHU Dijon and Registre Bourguignon des Cancers Digestifs, Faculté de Médecine (INSERM EPI 01-06, IFR 100), 7 Boulevard Jeanne d'Arc, 21079 Dijon Cedex, France.
Histopathology. 2003 Jul;43(1):40-7. doi: 10.1046/j.1365-2559.2003.01641.x.
The aim of this study was to assess the independent value of pathological criteria in the diagnosis of mismatch repair (MMR)-defective sporadic colorectal cancers.
Resected colorectal adenocarcinomas (n = 273) were reviewed in order to identify a number of specific morphological features of MMR-defective carcinomas. Of the 273 cases, 35.2% were right-sided and 5.9% were poorly differentiated. Focal extracellular mucin secretion was seen in 5.1% of cases and a stromal follicular reaction in 4.6%. The expression of the two major MMR proteins hMLH1 and hMSH2 was studied by immunohistochemistry. Carcinomas were considered deficient in the MMR system when a loss of nuclear signal in neoplastic cells was observed for one of the proteins. Such an extinction was seen in 37 of the cases (13.6%). The hMLH1 protein was the one most frequently altered (86.5%). After multivariate analysis, three independent factors were significantly associated with MMR deficiency: proximal location [odds ratio (OR) = 9.30; 95% confidence interval (CI) 2.79, 30.98], the presence of a true stromal follicular reaction (OR = 13.60; 95% CI 2.98, 62.00) and poor differentiation (OR = 8.33; 95% CI 1.63, 40.32).
These results confirm that sporadic colorectal MMR-defective adenocarcinomas display certain specific morphological characteristics. However, these pathological features are not sufficiently predictive and immunohistochemistry is needed to identify such tumours accurately.
本研究旨在评估病理标准在错配修复(MMR)缺陷型散发性结直肠癌诊断中的独立价值。
回顾性分析273例切除的结直肠腺癌,以确定MMR缺陷型癌的一些特定形态学特征。273例病例中,35.2%为右侧肿瘤,5.9%为低分化肿瘤。5.1%的病例可见局灶性细胞外黏液分泌,4.6%的病例可见间质滤泡反应。采用免疫组织化学方法研究两种主要MMR蛋白hMLH1和hMSH2的表达。当肿瘤细胞中一种蛋白的核信号缺失时,癌被认为存在MMR系统缺陷。37例病例(13.6%)出现这种缺失。hMLH1蛋白是最常发生改变的蛋白(86.5%)。多因素分析后,三个独立因素与MMR缺陷显著相关:肿瘤位于近端[比值比(OR)=9.30;95%置信区间(CI)2.79,30.98]、存在真正的间质滤泡反应(OR = 13.60;95% CI 2.98,62.00)和低分化(OR = 8.33;95% CI 1.63,40.32)。
这些结果证实散发性结直肠MMR缺陷型腺癌具有某些特定的形态学特征。然而,这些病理特征的预测性不足,需要免疫组织化学来准确识别此类肿瘤。